Last updated: February 19, 2018
Sponsor: University of Manitoba
Overall Status: Completed
Phase
N/A
Condition
Gliomas
Astrocytoma
Brain Tumor
Treatment
N/AClinical Study ID
NCT01866228
H2013:085
126049
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
presenting with a primary diagnosis of non-recurrent or metastatic brain, orneuroendocrine cancer
18 years of age or older
able to read and communicate using the English language
access to a computer to enable consultation playback
Exclusion
Exclusion Criteria:
- deemed by a treating clinician (or primary nurse for the treating clinician) to haveany severe psychiatric condition or cognitive dysfunction that precludes provision offree and informed consent to participate
Study Design
Total Participants: 140
Study Start date:
June 01, 2013
Estimated Completion Date:
December 31, 2017
Connect with a study center
Tom Baker Cancer Centre
Calgary, Alberta T2N 4N2
CanadaSite Not Available
British Columbia Cancer Agency
Vancouver, British Columbia
CanadaSite Not Available
Cancer Care Manitoba
Winnipeg, Manitoba R3E 0V9
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.